Cardioxane 500mg powder for solution for infusion Ref.[2737]
Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB) |  Revision Year: 2012 |  Publisher: Novartis Pharmaceuticals UK Limited Frimley Business Park Frimley Camberley Surrey GU16 7SR

Product name and form

CARDIOXANE 500mg, powder for solution for infusion.

Pharmaceutical Form

Powder for solution for infusion.

Sterile, pyrogen free, white to off-white, lyophilised powder.

Qualitative and quantitative composition

Dexrazoxane 500.00mg as its hydrochloride salt.

For a vial of powder.

For a full list of excipients, see section 6.1.

List of Excipients

Not applicable.

Pack sizes and marketing

Vials (Type I brown glass), containing 500 mg of powder, closed with a chlorobutyl rubber stopper and an aluminium cap with pre-cut strip. The product is further enclosed in an outer carton. It is supplied in packs of 1 and 4 vials. Not all pack sizes may be marketed.

Marketing authorization holder

Novartis Pharmaceuticals UK Limited
Frimley Business Park
Frimley
Camberley
Surrey
GU16 7SR

Marketing authorization dates and numbers

PL 00101/0937

1 September 2006 / 16 February 2012

Drugs

Drug
Countries
CARDIOXANE
Brazil, Ecuador, Spain, France, Hong Kong, Mexico, Netherlands, Poland, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈